These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28327523)

  • 1. Methodological Challenges in Protein Microarray and Immunohistochemistry for the Discovery of Novel Autoantibodies in Paediatric Acute Disseminated Encephalomyelitis.
    Peschl P; Ramberger M; Höftberger R; Jöhrer K; Baumann M; Rostásy K; Reindl M
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28327523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
    Baumann M; Sahin K; Lechner C; Hennes EM; Schanda K; Mader S; Karenfort M; Selch C; Häusler M; Eisenkölbl A; Salandin M; Gruber-Sedlmayr U; Blaschek A; Kraus V; Leiz S; Finsterwalder J; Gotwald T; Kuchukhidze G; Berger T; Reindl M; Rostásy K
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):265-72. PubMed ID: 25121570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis.
    Van Haren K; Tomooka BH; Kidd BA; Banwell B; Bar-Or A; Chitnis T; Tenembaum SN; Pohl D; Rostasy K; Dale RC; O'Connor KC; Hafler DA; Steinman L; Robinson WH
    Mult Scler; 2013 Nov; 19(13):1726-33. PubMed ID: 23612879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.
    Wong YYM; Hacohen Y; Armangue T; Wassmer E; Verhelst H; Hemingway C; van Pelt ED; Catsman-Berrevoets CE; Hintzen RQ; Deiva K; Lim MJ; Rostásy K; Neuteboom RF
    Eur J Neurol; 2018 May; 25(5):782-786. PubMed ID: 29443442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
    Baumann M; Hennes EM; Schanda K; Karenfort M; Kornek B; Seidl R; Diepold K; Lauffer H; Marquardt I; Strautmanis J; Syrbe S; Vieker S; Höftberger R; Reindl M; Rostásy K
    Mult Scler; 2016 Dec; 22(14):1821-1829. PubMed ID: 26869530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teaching Case 5-2018: Integrated morphological and immunological work-up of neurosurgical specimen allows accurate diagnosis of neuroinflammatory lesions: an example of acute disseminated encephalomyelitis (ADEM) associated with anti-MOG antibodies.
    Lang J; Biebl A; Gruber A; Maier-Hiebl B; Hainfellner JA; Höftberger R; Gelpi E
    Clin Neuropathol; 2018; 37(5):206-208. PubMed ID: 30103853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Disseminated Encephalomyelitis (ADEM) and Increased Intracranial Pressure Associated With Anti-Myelin Oligodendrocyte Glycoprotein Antibodies.
    Narayan RN; Wang C; Greenberg BM
    Pediatr Neurol; 2019 Oct; 99():64-68. PubMed ID: 31248672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.
    López-Chiriboga AS; Majed M; Fryer J; Dubey D; McKeon A; Flanagan EP; Jitprapaikulsan J; Kothapalli N; Tillema JM; Chen J; Weinshenker B; Wingerchuk D; Sagen J; Gadoth A; Lennon VA; Keegan BM; Lucchinetti C; Pittock SJ
    JAMA Neurol; 2018 Nov; 75(11):1355-1363. PubMed ID: 30014148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases.
    Spadaro M; Meinl E
    Methods Mol Biol; 2016; 1304():99-104. PubMed ID: 25814289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOG-IgG serological status matters in paediatric ADEM.
    Misu T; Sato DK; Nakashima I; Fujihara K
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):242. PubMed ID: 25136054
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of anti-MOG antibody-positive multiphasic disseminated encephalomyelitis co-occurring with unilateral cerebral cortical encephalitis].
    Fukushima N; Suzuki M; Ogawa R; Hayashi K; Takanashi JI; Ohashi T
    Rinsho Shinkeigaku; 2017 Nov; 57(11):723-728. PubMed ID: 29070756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
    Ketelslegers IA; Van Pelt DE; Bryde S; Neuteboom RF; Catsman-Berrevoets CE; Hamann D; Hintzen RQ
    Mult Scler; 2015 Oct; 21(12):1513-20. PubMed ID: 25662345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Adult Case of Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Multiphasic Acute Disseminated Encephalomyelitis at 33-year Intervals.
    Numa S; Kasai T; Kondo T; Kushimura Y; Kimura A; Takahashi H; Morita K; Tanaka A; Noto Y; Ohara T; Nakagawa M; Mizuno T
    Intern Med; 2016; 55(6):699-702. PubMed ID: 26984094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MOG Spectrum Disorders and Role of MOG-Antibodies in Clinical Practice.
    Hennes EM; Baumann M; Lechner C; Rostásy K
    Neuropediatrics; 2018 Feb; 49(1):3-11. PubMed ID: 28859212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
    O'Connor KC; McLaughlin KA; De Jager PL; Chitnis T; Bettelli E; Xu C; Robinson WH; Cherry SV; Bar-Or A; Banwell B; Fukaura H; Fukazawa T; Tenembaum S; Wong SJ; Tavakoli NP; Idrissova Z; Viglietta V; Rostasy K; Pohl D; Dale RC; Freedman M; Steinman L; Buckle GJ; Kuchroo VK; Hafler DA; Wucherpfennig KW
    Nat Med; 2007 Feb; 13(2):211-7. PubMed ID: 17237795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin Oligodendrocyte Glycoprotein Antibody Persistency in a Steroid-Dependent ADEM Case.
    Polat İ; Yiş U; Karaoğlu P; Ayanoğlu M; Öztürk T; Güleryüz H; Kurul SH
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Genetic Variants Distinguishing Myelin Oligodendrocyte Glycoprotein-IgG-Positive From Myelin Oligodendrocyte Glycoprotein-IgG-Negative Pediatric Acute Disseminated Encephalomyelitis in Northern China.
    Cui Y; Wu B; Wu J; Zhang S; Guo P; Shu J; Li D; Cai C
    Pediatr Neurol; 2024 Jul; 156():155-161. PubMed ID: 38781724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent presence of the anti-myelin oligodendrocyte glycoprotein autoantibody in a pediatric case of acute disseminated encephalomyelitis followed by optic neuritis.
    Miyauchi A; Monden Y; Watanabe M; Sugie H; Morita M; Kezuka T; Momoi M; Yamagata T
    Neuropediatrics; 2014 Jun; 45(3):196-9. PubMed ID: 24610298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
    Hennes EM; Baumann M; Schanda K; Anlar B; Bajer-Kornek B; Blaschek A; Brantner-Inthaler S; Diepold K; Eisenkölbl A; Gotwald T; Kuchukhidze G; Gruber-Sedlmayr U; Häusler M; Höftberger R; Karenfort M; Klein A; Koch J; Kraus V; Lechner C; Leiz S; Leypoldt F; Mader S; Marquard K; Poggenburg I; Pohl D; Pritsch M; Raucherzauner M; Schimmel M; Thiels C; Tibussek D; Vieker S; Zeches C; Berger T; Reindl M; Rostásy K;
    Neurology; 2017 Aug; 89(9):900-908. PubMed ID: 28768844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.